Diabetic Ketoacidosis
Is a state of acidaemia induced by excess production of ketoacids, Dehydration and hyperglycaemia are the rule, lactic acidosis may also be present.[1]
Pathophysiology –
Diabetic ketoacidosis is caused by severe insulin deficiency and is accentuated by excessive glucagon secretion. This leads to major clinical and laboratory abnormalities seen in diabetic ketoacidosis, which includes excess mobilization of free acids from adipose tissue, increased glucose production from the liver and impaired glucose uptake and utilization by muscle.
The two major effects of uncontrolled diabetes are:
- Increased glucose production which causes hyperglycaemia, osmotic diuresis, electrolyte depletion and dehydration
- Increased ketogenesis, resulting in metabolic acidosis.
Diagnosis –
The cardinal features are:
- Acidosis (arterial pH ≤ 7.3)
- Plasma anion gap (≥ 16 mmol/liter)
- Serum ketone is positive
- Serum bicarbonate ≥ 15 mmol/liter
- Hyperglycaemia (plasma glucose ≥ 11.1 mmol/liter)
Investigations:
Blood glucose, urea and electrolytes (especially potassium), full blood count and blood gases. ECG should be monitored continuously for signs of hypokalaemia.[1]
Management:
Admission
- Diagnosis suspected and confirmed immediately by blood glucose and ketone measurements
- Initial assessment of magnitude of dehydration, hyperosmolality, and acidosis
- Fluid loss measured by subtracting admission weight from last recently known stable weight
- Effective serum osmolality = 2 × [serum Na+ (mmol/liter) + serum K + (mmol/liter)] + serum glucose (mmol/liter) + urea
- Evaluate patient for sepsis and/or precipitating illness [1]
Hour 1
– If strikingly hypovolaemic with low blood pressure and relative or absolute anuria, fluid administration should be normal saline and, if necessary, colloids; rate of administration should be that necessary to restore circulatory function
– When blood pressure is normal and urine output adequate: fluid administration should be normal saline; rate of (mmol/liter)] administration 1000 mL/hour
- Initial assessment of serum potassium and kidney function.
- Insulin
– Continuous intravenous infusion of regular insulin 5–10 units/ hour or intramuscular regular insulin (20 units loading dose and 5 units/hour) Potassium
– Start intravenous potassium at 10–40 mmol/hour at initiation of insulin therapy if serum potassium is not > 5 mmol/litter and renal output is good. If patient is hyperkaliaemic, temporary delay intravenous potassium Alkali
– Sodium bicarbonate intravenously is seldom indicated, except in severe acidosis (pH < 7.0) with incipient circulatory collapse Dose, if given, is 50–100 mmol/litter sodium bicarbonate given in 0.45% saline over 30–60 minutes. Additional K + must be given with bicarbonate therapy
Hour 2
- Fluid administration
- Continue normal saline at 500 mL/hour. Maintain calculated plasma osmolality > 285 mOsmol/liter throughout the first 12 hours. If serum Na + >150 mmol/liter switch to 0.45% saline
- Insulin
- Check blood glucose and adjust insulin dose to maintain a fall of about 5 mmol/litre/hour. Do not allow blood glucose to fall below 11.1–14.0 mmol/litre. Anion gap should be decreasing and blood pH increasing
- Potassium
- Maintain serum potassium at 4.0–5.0 mmol/litre by continued addition of potassium to intravenous fluids[1]
Hours 3-4
Continue as for hour 2
Observe for cognitive or neurological symptoms and continue to do so for 12 hours
Hours 5-8
– Normal saline 250 mL/hour. When blood glucose reaches 11.1–14.0 mmol/liter, change intravenous fluid to 500 mL/ hour normal saline with 5% glucose
– Continue insulin at maintenance dose until ketoacidosis has cleared (blood pH > 7.35, serum ketones negative)
– Continue at 10–40 mmol/hour until ketoacidosis has cleared
– Consider phosphate replacement at 6 hours if serum phosphate is < 2.0 mg/dL
Hours 8-24
– Continue intravenous repletion with 0.45% saline with or without 2.5% or 5.0% glucose as needed
– After ketoacidosis has cleared (blood pH > 7.35, serum ketones negative) switch to subcutaneous insulin and then stop intravenous or intramuscular insulin.
Complications of DKA
Iatrogenic complications
Osmotic and volume disturbances–
Administration of insulin without sufficient fluids causes shift of water from extracellular space; further shrinking of extracellular fluid volume impairs blood flow to critical vascular beds, or precipitates vascular collapse. Similarly, insufficient saline administration may also result in hypotension.
Potassium disturbances –
Premature (before insulin has begun to act) and inappropriate potassium administration may cause fatal hyperkalaemia (cardiotoxicity) in early course of management. Glucose, insulin, and volume expansion with normal saline are potential modalities for lowering serum potassium; hence failure to administer potassium in latter stages may cause fatal hypokalaemia in potassium depleted patient.[1]
Hypoglycaemia and reappearance of ketosis –
During therapy of DKA, normalization of blood glucose usually achieve sooner than reversal of ketoacidosis state. Because insulin therapy must continue, hypoglycaemia develops unless glucose is given.
Fingerstick glucose measurements should done hourly for 4h, 2 hourlies for next 4h, and 4 hourlies till pt. improves. Glucose generally falls at rate of 50–100 mg/ dL/h. Failure to maintain glucose and insulin treatment until ketones have clear and depleted glycogen stores restored, results in recurrence of ketosis
Cerebral oedema –
It may rarely occur in children but is even rarer in adults. The condition should suspect when a pt. with ketoacidosis begins to deteriorate 3 to 10 hours into treatment with increasing stupor or coma coupled with signs of raised intracranial pressure; an unexpected fever may also an early sign. Osmotic disequilibrium between intracellular and extracellular fluids probably plays a role. Tr. – Mannitol 20% iv 1.5–2 mL/kg body wt. over 15 minutes and dexamethasone 10 mg iv followed by 4mg in q6h. Clinical response will seen in 12–24 h.
Hypocalcaemia –
It may develop during phosphate replacement.[1]
Non-iatrogenic complications
Infection –
Although leucocytosis may occur in DKA in absence of infection, fever generally indicates infection and demands careful search for pneumonia, pyelonephritis and septicaemia. A Rare ketoacidosis-associated infection is mucormycosis of paranasal sinuses with facial pain, bloody nasal discharge, orbital swelling, blurred vision and impaired consciousness. Tr. – Broad spectrum antibiotics. Blood, Urine and throat cultures should be taken prior to giving antibiotic.
Vascular thrombosis –
Combination of volume contraction, low cardiac output, increased blood viscosity, underlying atherosclerosis, direct endothelial damage due to hyperosmolar milieu, and changes in clotting factors and platelet function predispose to thrombosis.
Respiratory distress syndrome i.e.–
Hypoxia and ARDS may develop in course of therapy of DKA hyperosmolar coma. Additionally, Clinical picture is characterized by unexplained hypoxaemia and dyspnoea in absence of any underlying pulmonary/cardiac disease.
Pancreatitis i.e.–
Acute abdominal pain is a common presentation of DKA, and resolves rapidly on therapy. specific aetiologies can be gastroparesis, ischaemic bowel, and cholecystitis. Raised serum amylase is observed in 80% of cases. It may represent pancreatic damage (in other words; hypertonicity and hyper perfusion); in some instances, it is subclinical.
Myocardial infarction i.e.–
can precipitate or complicate DKA, it is a major cause of morbidity.
Hyperlipidaemia –
Severe hypertriglyceridemia (triglycerides > 1000 mg/dl) is seen in about 10% which on follow-up resolve in 70% of cases. The abnormality is related to acute metabolic changes in DKA.[1]